s6y
Company name or ticker
Search
SAB Biotherapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Thursday, April 30, 2026
Period
Jun 18, 2026
Accession number
0001193125-26-197607
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header